Latest filing published 30 Mar 2015 for Navidea Biopharmaceuticals, INC..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Thomas H. Tulip: trading record in brief
Thomas H. Tulip appears in our data through filings on Navidea Biopharmaceuticals, Inc. shares, published by SEC (Form 4). We count 8 filings; the first trade dates from 9 December 2011 and the latest from 26 March 2015.
Purchases make up the whole of the open-market record (2 purchases, €69k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 5 share grants.
On 30 March 2015 came the latest disclosure, a share grant in Navidea Biopharmaceuticals, Inc. The latest purchase dates back some time: it was published 4,984 days ago, on 18 March 2013. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Thomas H. Tulip
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,000 shares0Common StockSEC:0001144204-15-019381:0
- 7,645 shares@ US$1.65Common StockSEC:0001144204-15-019381:1
- 20,000 shares0Common StockSEC:0001144204-14-060147:0
- 6,582 shares@ US$1.34Common StockSEC:0001144204-14-060147:1
- 17,500 shares@ US$2.82Common StockSEC:0001144204-13-015636:0Canonical exit: 13 Jun 2013 (T+90)
- 15,000 shares@ US$2.70Common StockSEC:0001225208-12-019632:0Canonical exit: 13 Dec 2012 (T+90)
- 7,500 shares@ US$2.69Common StockSEC:0001225208-12-010104:0
- 20,000 shares0Common StockSEC:0001225208-12-004960:0
8 of 8 declarations